Osteoporosis Medication: What to Expect Before You Start

Bone medication is offered to lower your chance of breaking something, not to move a score, and the honest way to weigh it is against your own fracture risk rather than against the frightening rare side effects that dominate the search results.

The letter arrives, the word osteoporosis is in it, and a few weeks later somebody offers you a tablet you are expected to take for years. That is the point at which most women I know start reading, and reading is where the trouble begins: the first page of results is jaws and thigh bones, and nothing on that page tells you what the treatment is for. This is the orientation I wish I had had before that appointment, so you can arrive with questions rather than dread.

What the medication is actually for

It is for fractures. Not for a number on a report, not for a feeling, for the hip or spine or wrist that breaks in your seventies and changes what your life looks like afterwards. Fragility fractures are a leading cause of disability and lost independence in older adults, and roughly 1 in 3 women over 50 will have one in her lifetime ^{1 2}.

That is why the decision to treat is rarely made on a T-score alone. Your clinician is weighing the density result together with your age, any previous fracture, a parent’s broken hip, steroid use, smoking, low body weight, and other conditions that affect bone, often through a fracture risk calculator such as FRAX ^{3 4}. Two women with the same score can reasonably be given different advice, which is worth knowing before you compare notes with a friend and panic.

The main classes, in plain terms

Bisphosphonates are the usual starting point. They slow the cells that break bone down, which lets the rebuilding side catch up. Some are tablets taken weekly or monthly, and one is given as an intravenous infusion once a year ⁵. The tablets have fussy instructions for a reason: absorption is poor, so they are taken with plain water on an empty stomach, and you stay upright afterwards to protect the food pipe. The infusion sidesteps all of that and commonly causes a day or two of flu-like aching the first time.

Denosumab is a different mechanism, an antibody treatment given by injection twice a year ⁵. The point to raise at the start, not at the end, is that its effect does not linger after stopping, so it is not a medicine to simply drop; a follow-on plan is part of prescribing it.

Hormone-related options include menopausal hormone therapy, which protects bone, and raloxifene, a selective estrogen receptor modulator used in some postmenopausal women ⁵. If your joints ache in the same window, our article on menopause and joint pain covers where hormone therapy sits in that discussion.

Bone-building (anabolic) treatments such as teriparatide and romosozumab work the other way round, stimulating new bone formation rather than slowing loss. They are reserved for women at high fracture risk, typically given for a limited period, and are usually followed by a bisphosphonate or similar to hold the gain ⁵.

The side effects everybody has read about

Two of them get all the traffic, and both deserve a straight answer rather than reassurance or alarm.

Osteonecrosis of the jaw is an area of jawbone that fails to heal, most often after a dental extraction or invasive dental work. It is rare at osteoporosis treatment doses, and it is seen more in cancer patients receiving much higher doses ⁵. The practical response is not to refuse treatment, it is to get outstanding dental work done, keep your mouth in good order, and make sure your dentist knows what you are taking.

Atypical femoral fracture is an unusual break in the thigh bone associated with long-term treatment, and it is likewise rare ⁵. The symptom worth remembering is a new, dull, persistent ache in the thigh or groin that builds over weeks, which is a reason to get it looked at rather than to wait.

The everyday side effects are more mundane and more likely: heartburn or indigestion with oral bisphosphonates, transient flu-like symptoms after an infusion, and injection-site reactions. Those are the ones that actually decide whether women keep taking a medicine, and they are often fixable by switching form or timing.

The foundation underneath the drug

No medicine is asked to work on its own. Adequate calcium (ideally from food) and vitamin D are assumed as the base of every treatment plan, and deficiency undermines both bone and muscle ⁴. Weight-bearing and resistance exercise continues to matter after starting treatment, because it supports bone density and reduces falls, and a medicine cannot help with the falling half of a fracture ⁶. That half is covered in our guide to preventing falls and fractures after 50, and the background on scans and scores is in osteoporosis and bone health after 50.

How long, and how you will know it is working

Treatment is reviewed rather than assumed to be for life. Oral bisphosphonates are commonly reassessed after about five years and intravenous treatment after about three, after which some women pause and some continue because their risk remains high ⁵. Other classes have their own rules, which is exactly why the length of the plan belongs in the first conversation.

Knowing it is working is oddly unsatisfying, because success is a fracture that never happens. Monitoring usually means a repeat bone density scan after a couple of years, where a stable score counts as a good result and small movements can sit inside the scan’s own margin of error ⁴. If you are heading towards joint surgery in the same period, bone quality is part of that picture too, and your medication list belongs in the pre-operative conversation covered in preparing for knee replacement.

Four questions are enough to make the appointment useful. What is my fracture risk, not just my score. Why this medicine for me. What do we do if I cannot tolerate it. And when do we review, and what happens then.

This article is general information, not medical advice. Decisions about starting, changing, or stopping any medication belong to you and a qualified clinician.